A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Johnson & Johnson JNJ is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing ...

DelveInsight's VEGFR-2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

FutureWise Research today announces the upcoming release of its comprehensive report, Alzheimer’s Disease Diagnostic Market – ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

United States-based pharmaceutical company Eli Lilly will continue to pour research and development investments in China to accelerate local pharmaceutical innovations and benefit the patients, said a ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and ...

Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...